Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
NCT03089476 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2018-06-12
Summary
It is hypothesized that food allergy is preceded by atopic dermatitis (AD), due to a disruption of skin barrier which can predispose one to food sensitization through the skin. The central hypothesis is that increased transepidermal water loss (TEWL) assessment and skin tape strip analysis (STS) of lipid and filaggrin breakdown products will be predictive markers for the development of AD. Additionally, the associated changes in TEWL and STS will further improve the identification of infants at risk of early food sensitization, compared to family history alone.
Conditions
Interventions
- OTHER
-
Evaluating atopy in infants
This study does not have an intervention. There is the evaluation of the predictive value of TEWL and STS in atopic infants at risk of developing eczema and TEWL and STS in parents of infants.
- OTHER
-
Evaluating TEWL and STS in adults
This study does not have an intervention. There is the evaluation of the predictive value of TEWL and STS in atopic infants at risk of developing eczema and TEWL and STS in parents of infants.
Sponsors & Collaborators
-
National Jewish Health
lead OTHER
Principal Investigators
-
Pia Hauk, MD · National Jewish Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 34 Weeks
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-09-30
- Primary Completion
- 2018-07-30
- Completion
- 2018-07-30
Countries
- United States
Study Locations
More Related Trials
-
A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study
NCT03143504 ·Status: UNKNOWN
-
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis
NCT00828412 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis
NCT01065714 ·Status: COMPLETED ·Phase: PHASE4
-
Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis
NCT04718870 ·Status: COMPLETED ·Phase: PHASE4
-
Atopic Dermatitis in Atopy Predisposed Infants
NCT02906475 ·Status: COMPLETED ·Phase: NA
-
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359 ·Status: ACTIVE_NOT_RECRUITING
-
Frequency of Food Allergy Confirm by Oral Food Challenge Among Foods Avoidance in Atopic Dermatitis Children
NCT06947252 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
NCT03389893 ·Status: TERMINATED ·Phase: PHASE4
-
Detection of Skin Epithelial Barrier in Patients With Allergic Skin Disorders
NCT03581747 ·Status: UNKNOWN
-
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
NCT00806221 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Topical Application to Prevent Atopic Dermatitis
NCT03871998 ·Status: COMPLETED ·Phase: NA
-
Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy
NCT02763722 ·Status: UNKNOWN ·Phase: NA
-
Sodium in the Skin and Atopic Dermatitis
NCT06998446 ·Status: RECRUITING
-
Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China
NCT05680298 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
NCT06943469 ·Status: RECRUITING ·Phase: NA
-
Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients
NCT01695707 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03864627 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis
NCT04462055 ·Status: TERMINATED
-
Dupilumab Skin Barrier Function Study in Atopic Dermatitis
NCT04447417 ·Status: COMPLETED ·Phase: PHASE4
-
Pimecrolimus and Epidermal Barrier Function
NCT01132079 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis
NCT03059693 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus Cream
NCT02153762 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children
NCT00886587 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens
NCT00557284 ·Status: COMPLETED ·Phase: PHASE4
-
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
NCT01782703 ·Status: ACTIVE_NOT_RECRUITING